FDA 510(k) vs PMA: What GalaFLEX Patients Should Know

GalaFLEX entered the market through the FDA 510(k) process, which focuses on substantial equivalence to existing devices rather than the full premarket approval standard used for many high-risk products.

In litigation, this distinction may matter because plaintiffs often argue that market clearance did not guarantee long-term safety outcomes for the way the mesh was used in real-world breast surgeries.

Understanding the regulatory pathway helps patients evaluate how warning, design, and post-market evidence issues can arise in product liability claims.